| Product Name | Human G antigen 7 (GAGE7) ELISA Kit |
|---|---|
| Description | Many human tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. The MAGE (melanoma-specific antigen) and GAGE (G antigen) gene family members encode such antigens. To screen for genes associated with cancer progression, Chen et al. (1998) performed differential display PCR using sublines of the nontumorigenic, prostate-specific antigen (PSA)-secreting cell line LNCaP that differed in androgen sensitivity and metastatic potential. They isolated 2 members of the GAGE family, GAGEB1 and GAGE7. GAGE7 encodes a 117-amino acid polypeptide that contains 3 potential casein kinase phosphorylation sites, 2 potential protein kinase C phosphorylation sites, and 1 potential N-myristoylation site. Levels of GAGE7 mRNA were not correlated to the degree of tumorigenicity of prostate cancer cell lines. This assay has high sensitivity and excellent specificity for detection of Human GAGE7. No significant cross-reactivity or interference between Human GAGE7 and analogues was observed. |
| Synonyms | CT4.7, GAGE-7, cancer/testis antigen family 4, member 7 |
| Method | Sandwich ELISA |
| Detection Range | 0.156-10 ng/mL |
| Sensitivity | 0.057 ng/mL |
| Reactivity | Human |
| Sample Types | Serum, Plasma, Other biological fluids. |
| Background | Many human tumors express antigens that are recognized in vitro by cytolytic T lymphocytes (CTLs) derived from the tumor-bearing patient. The MAGE (melanoma-specific antigen) and GAGE (G antigen) gene family members encode such antigens. To screen for genes associated with cancer progression, Chen et al. (1998) performed differential display PCR using sublines of the nontumorigenic, prostate-specific antigen (PSA)-secreting cell line LNCaP that differed in androgen sensitivity and metastatic potential. They isolated 2 members of the GAGE family, GAGEB1 and GAGE7. GAGE7 encodes a 117-amino acid polypeptide that contains 3 potential casein kinase phosphorylation sites, 2 potential protein kinase C phosphorylation sites, and 1 potential N-myristoylation site. Levels of GAGE7 mRNA were not correlated to the degree of tumorigenicity of prostate cancer cell lines. |
| Supplier | Abebio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
